Psychedelic Stocks

Psychedelics, such as psilocybin and DMT, are a class of powerful psychoactive substances that affect mood and cognitive processes. While still federally illegal under U.S. law, some states have voted to partially decriminalize the substances. Meanwhile, companies like ATAI Life Sciences and Compass Pathways have taken the initiative of developing psychedelic drugs to treat disorders like PTSD and depression.